Skip to Main Content

Paper Details

B-cell-specific checkpoint molecules that regulate anti-tumour immunity.
Nature
22
2023
B, B cell subset, B cells, B-cell, B16F10 melanoma, Havcr1, LAG-3, PD-1, T and natural killer cells, T cell immunoglobulin, TIGIT, TIM-1, TIM-1-expressing B cells, TIM-3, anti-, effector T cell, mice, mucin domain 1, single, tumour, tumour-specific effector T cells, type 1 interferon
Author NameAffiliation
Orr AshenbergBroad Institute of MIT and Harvard
David E FisherMassachusetts General Hospital
David E FisherMassachusetts General Hospital
Orit Rozenblatt-RosenBroad Institute of MIT and Harvard
Orit Rozenblatt-RosenHoward Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv RegevBroad Institute of MIT and Harvard
Aviv RegevHoward Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv Regev
Aviv RegevBroad Institute of MIT and Harvard
Aviv RegevHoward Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv Regev
  • 1 - 11

Datasets

Release 1.2